These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
110 related articles for article (PubMed ID: 7296499)
1. Androgen-induced remissions after antiestrogen and hypophysectomy in stage IV breast cancer. Manni A; Arafah BM; Pearson OH Cancer; 1981 Dec; 48(11):2507-9. PubMed ID: 7296499 [TBL] [Abstract][Full Text] [Related]
2. Antiestrogen-induced remissions in stage IV breast cancer. Manni A; Trujillo J; Marshall JS; Pearson OH Cancer Treat Rep; 1976 Oct; 60(10):1445-50. PubMed ID: 1021225 [TBL] [Abstract][Full Text] [Related]
3. Antiestrogen treatment of breast cancer: an overview. Pearson OH; Manni A; Arafah BM Cancer Res; 1982 Aug; 42(8 Suppl):3424s-3429s. PubMed ID: 7044524 [TBL] [Abstract][Full Text] [Related]
4. Treatment of breast cancer with antiestrogen: approach to medical hypophysectomy? Manni A; Trujillo J; Brodkey J; Marshall JS; Pearson OH Trans Assoc Am Physicians; 1977; 90():342-52. PubMed ID: 611666 [TBL] [Abstract][Full Text] [Related]
5. Sequential endocrine therapy and chemotherapy in metastatic breast cancer: effects on survival. Manni A; Pearson OH; Marshall JS; Arafah BM Breast Cancer Res Treat; 1981; 1(2):97-103. PubMed ID: 6184099 [TBL] [Abstract][Full Text] [Related]
6. Antihormone treatment of stage IV breast cancer. Manni A; Trujillo JE; Marshall JS; Brodkey J; Pearson OH Cancer; 1979 Feb; 43(2):444-50. PubMed ID: 421171 [TBL] [Abstract][Full Text] [Related]
7. Tamoxifen and fluoxymesterone in advanced breast cancer: a controlled clinical trial. Westerberg H Cancer Treat Rep; 1980 Jan; 64(1):117-21. PubMed ID: 6991101 [TBL] [Abstract][Full Text] [Related]
8. Role of pituitary hormones in the growth of human breast cancer. Pearson OH; Manni A; Chambers M; Brodkey J; Marshall JS Cancer Res; 1978 Nov; 38(11 Pt 2):4323-6. PubMed ID: 212192 [TBL] [Abstract][Full Text] [Related]
9. Fluoxymesterone as third line endocrine therapy for advanced breast cancer. A phase II trial of the Piedmont Oncology Association. Schifeling DJ; Jackson DV; Zekan PJ; Muss HB Am J Clin Oncol; 1992 Jun; 15(3):233-5. PubMed ID: 1590276 [TBL] [Abstract][Full Text] [Related]
10. Comparison of tamoxifen and hypophysectomy in breast cancer treatment. Kiang DT; Frenning DH; Vosika GJ; Kennedy BJ Cancer; 1980 Mar; 45(6):1322-5. PubMed ID: 6986976 [TBL] [Abstract][Full Text] [Related]
11. Transsphenoidal hypophysectomy in breast cancer: evidence for an individual role of pituitary and gonadal hormones in supporting tumor growth. Manni A; Pearson OH; Brodkey J; Marshall JS Cancer; 1979 Dec; 44(6):2330-7. PubMed ID: 509401 [TBL] [Abstract][Full Text] [Related]
12. Combination hormonal therapy with tamoxifen plus fluoxymesterone versus tamoxifen alone in postmenopausal women with metastatic breast cancer. An updated analysis. Ingle JN; Twito DI; Schaid DJ; Cullinan SA; Krook JE; Mailliard JA; Tschetter LK; Long HJ; Gerstner JG; Windschitl HE Cancer; 1991 Feb; 67(4):886-91. PubMed ID: 1991261 [TBL] [Abstract][Full Text] [Related]
13. Short term high density systemic therapy for metastatic breast cancer. Tormey DC; Kline JC; Palta M; Davis TE; Love RR; Carbone PP Breast Cancer Res Treat; 1985; 5(2):177-88. PubMed ID: 2410072 [TBL] [Abstract][Full Text] [Related]
14. Evaluation of tamoxifen doses with and without fluoxymesterone in advanced breast cancer. Tormey DC; Lippman ME; Edwards BK; Cassidy JG Ann Intern Med; 1983 Feb; 98(2):139-44. PubMed ID: 6824247 [TBL] [Abstract][Full Text] [Related]
15. Estrogen and progesterone receptors in the prediction of response of breast cancer to endocrine therapy. Manni A; Arafah B; Pearson OH Cancer; 1980 Dec; 46(12 Suppl):2838-41. PubMed ID: 7448730 [TBL] [Abstract][Full Text] [Related]
16. Hypophysectomy for stage IV breast cancer. Pearson OH; Brodkey JS; Manni A Surg Clin North Am; 1978 Aug; 58(4):809-17. PubMed ID: 684562 [TBL] [Abstract][Full Text] [Related]
17. [Present status of endocrine therapy of breast cancer: a surgeon's view]. Nomura Y Gan To Kagaku Ryoho; 1984 May; 11(5):981-8. PubMed ID: 6426405 [TBL] [Abstract][Full Text] [Related]
18. Tamoxifen. Use in treatment of metastatic breast cancer refractory to combination chemotherapy. Legha SS; Buzdar AU; Hortobagyi GN; Wiseman C; Benjamin RS; Blumenschein GR JAMA; 1979 Jul; 242(1):49-52. PubMed ID: 448865 [TBL] [Abstract][Full Text] [Related]
19. Combination hormonotherapy with tamoxifen and fluoxymesterone in patients with advanced breast cancer relapsing on hormonotherapy. Goldhirsch A; Leuenberger U; Ryssel HJ; Cavalli F; Sonntag RW; Joss RA; Brunner KW Oncology; 1982; 39(5):284-6. PubMed ID: 7048171 [TBL] [Abstract][Full Text] [Related]
20. Tamoxifen (antiestrogen) therapy in advanced breast cancer. Kiang DT; Kennedy BJ Ann Intern Med; 1977 Dec; 87(6):687-90. PubMed ID: 931204 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]